** = Publications listed in SCI/SSCI/Pubmed
** Auer, T; Sauseng, S; Delcev, P; Kohek, P
Effect of Negative Pressure Therapy on Open Abdomen Treatments. Prospective Randomized Study With Two Commercial Negative Pressure Systems.
FRONT SURG. 2020; 7: 596056-596056.
Doi: 10.3389/fsurg.2020.596056
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, T; Wiederstein-Grasser, I; Sauseng, S; Delcev, P; Preisegger, KH
The Effect of Negative Pressure in the Abdominal Cavity With Suprasorb CNP on Abdominal Organs-An Experimental Study.
FRONT SURG. 2020; 7: 584926-584926.
Doi: 10.3389/fsurg.2020.584926
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Baltic, A; Laback, C; Auer, T; Leithner, A; Bernhardt, GA
Incarcerated hernia after internal hemipelvectomy for G2 chondrosarcoma: a preventable complication?
ANZ J Surg. 2020; 90(3):381-383
Doi: 10.1111/ans.15148
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Auer, T; Kniepeiss, D; Schemmer, P
Response to the letter on "Comments to 'PRevention of INCisional hernia after liver transplantation (PRINC trial): study protocol for a randomized controlled trial' by Janusz Strzelczyk".
Trials. 2020; 21(1):326-326
Doi: 10.1186/s13063-020-04244-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Waha, JE; Auer, T; Berghold, A; Schemmer, P
PRevention of INCisional hernia after liver transplantation (PRINC trial): study protocol for a randomized controlled trial.
Trials. 2019; 20(1):371-371
Doi: 10.1186/s13063-019-3477-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kniepeiss, D; Auer, T; Waha, J; Homfeld, N; Schemmer, P
INCISIONAL HERNIA REPAIR IN PATIENTS AFTER LIVER TRANSPLANTATION WITH POLY-4-HYDROXYBUTYRATE MESH
TRANSPL INT. 2017; 30: 40-41.
[Oral Communication]
Web of Science
** Kniepeiss, D; Wagner, D; Homfeld, N; Kahn, J; Schaffellner, S; Schemmer, P; Auer, T
INCISIONAL HERNIA AFTER LIVER TRANSPLANTATION - AN UNSOLVED PROBLEM
TRANSPL INT. 2017; 30: 451-452.-Österreichischer Chirurgenkongress; Juni 28-30; Wien.
[Oral Communication]
Web of Science
** Schest, E; Cerwenka, H; Hofler, B; Rigler, M; Auer, T; Dorr, K; Mischinger, HJ
Giant mesenteric lymphangioma.
Dig Surg. 2009; 26(4):289-290
Doi: 10.1159/000227770
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uranues, S; Alimoglu, O; Todoric, B; Toprak, N; Auer, T; Rondon, L; Sauseng, G; Pfeifer, J
Laparoscopic resection of the pancreatic tail with splenic preservation.
Am J Surg. 2006; 192(2):257-261
Doi: 10.1016/j.amjsurg.2006.01.031
Web of Science
PubMed
FullText
FullText_MUG
** Khoschsorur, G; Auer, T; Hoebart, G; Jorg-Schaur, R
A non-statistical approach to the prediction of regular structures in proteins by the example of alpha-helices
Bioorganicheskaia khimiia. 2003; 28(6): 483-490.
Web of Science
PubMed
** Khoschsorur, G; Auer, T; Schaur, RJ
Of malondialdehyde (MDA) in human plasma, urine, wound secretions anamniotic fluid using high-performance liquid chromatography with spectrofluorometric detection.
FREE RADICAL BIOL MED 2002 33: 496-496.
Web of Science
** Auer, T; Aichhorn, R; Khoschsorur, G; Hobarth, G
Effect of antioxidative treatment in cardiac bypass operations
In: Pasquier, C. editors(s). XI BIENNIAL MEETING OF THE SOCIETY FOR FREE RADICAL RESEARCH INTERNATIONAL; 383-387. (ISBN: 88-323-2716-3) ( Presented at: 11th Biennial Meeting of the Society-for-Free-Radical-Research-International, PARIS, FRANCE, JUL 16-20, 2002)
Web of Science
** Khoschsorur, GA; Winklhofer-Roob, BM; Rabl, H; Auer, T; Peng, Z; Schaur, RJ
Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials
CHROMATOGRAPHIA 2000 52: 181-184.
Doi: 10.1007/BF02490453
Web of Science
FullText
FullText_MUG
** Khoschsorur, G; Auer, T; Lanzer, G; Petritsch, P; Holzer, H; Tscheliessnigg, KH
The determination of metabolite M17 and its meaning for immunosuppressive cyclosporin therapy.
Angiology. 1998; 49(4):307-314
Doi: 10.1177/000331979804900409
Web of Science
PubMed
FullText
FullText_MUG
** Khoschsorur, G; Semmelrock, HJ; Rödl, S; Auer, T; Petek, W; Iberer, F; Tscheliessnigg, KH
Rapid, sensitive high-performance liquid chromatographic method for the determination of cyclosporin A and its metabolites M1, M17 and M21.
J Chromatogr B Biomed Sci Appl. 1997; 690(1-2):367-372
Doi: 10.1016/S0378-4347(96)00364-7
Web of Science
PubMed
FullText
FullText_MUG
** Auer, T; Schreier, G; Hutten, H; Kleinert, R; Wasler, A; Petutschnigg, B; Iberer, F; Tscheliessnigg, K; Schaldach, M
Paced epimyocardial electrograms for noninvasive rejection monitoring after heart transplantation
J Heart Lung Transplant. 1996; 15(10):993-998
Web of Science
PubMed
** Auer, T; Schreier, G; Tscheliessnigg, KH; Hutten, H; Allmayr, T; Grasser, B; Wasler, A; Petutschnigg, B; Iberer, F; Schaldach, M
Evoked epimyocardial electrogram for rejection diagnosis after heart transplantation.
Transpl Int. 1996; 9 Suppl 1(3):S243-S246
Doi: 10.1007/978-3-662-00818-8_63
PubMed
FullText
FullText_MUG
** Auer, T; Weihs, W; Grasser, B; Schmidt, B; Petutschnigg, B; Wasler, A; Iberer, F; Tscheliessnigg, KH
Donor heart quality control. Analysis of echocardiographic (EC) findings and patient outcome.
Transpl Int. 1996; 9 Suppl 1(3):S409-S413
Doi: 10.1007/978-3-662-00818-8_98
PubMed
FullText
FullText_MUG
** Egger, G; Allmayer, T; Iberer, F; Tscheliessnigg, KH; Auer, T; Wasler, A; Petutschnigg, B
Impaired Polymorphonuclear Leukocyte Migration as a Possible Monitor for the Risk of Septicemia in Immunosuppressed Transplant Patients
MED SCI RES 1996 24: 17-19.
Web of Science
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayr, T; Prenner, G; Hipmair, G; Grasser, B; Freigassner, M
Cytomegalovirus antigenemia as a marker for antiviral therapy after heart transplantation.
J Heart Lung Transplant. 1996; 15(3):314-315
Web of Science
PubMed
** Auer, T; Khoschsorur, GA; Rabl, H; Iberer, F; Petutschnigg, B; Wasler, A; Tscheliessnigg, KH
Detection of lipid peroxidation products by malondialdehyde (MDA-TBA reaction) in organ transplantation.
Transplant Proc. 1995; 27(5):2749-2751
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Schaldach, M; Iberer, F; Petutschnigg, B; Wasler, A; Müller, H; Allmeyer, T; Tscheliessnigg, KH
Intramyocardial electrograms for monitoring of allograft rejection after heart transplantation.
Transplant Proc. 1995; 27(3):1983-1985
Web of Science
PubMed
** Auer, T; Schreier, G; Hutten, H; Tscheliessnigg, KH; Allmayr, T; Grasser, B; Iberer, F; Wasler, A; Petutschnigg, B; Müller, H
Intramyocardial electrograms for the monitoring of allograft rejection after heart transplantation using spontaneous and paced beats.
Transplant Proc. 1995; 27(5):2621-2624
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, K; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Schreier, G; Müller, H; Allmayer, T; Prenner, G
Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
Scand J Infect Dis Suppl. 1995; 99(3):100-103
Web of Science
PubMed
** Iberer, F; Tscheliessnigg, KH; Halwachs, G; Auer, T; Wasler, A; Petutschnigg, B; Müller, H; Freigassner, M; Allmayr, T; Hipmair, G
CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
Wien Klin Wochenschr. 1995; 107(23):718-722
Web of Science
PubMed
** Wasler, A; Iberer, F; Auer, T; Petutschnigg, B; Müller, H; Pfeifer, J; Deutsch, T; Tscheliessnigg, KH
Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Transplant Proc. 1995; 27(5):2633-2634
Web of Science
PubMed
** Iberer, F; Halwachs-Baumann, G; Rödl, S; Pleisnitzer, A; Wasler, A; Auer, T; Petutschnigg, B; Müller, H; Tscheliessnigg, K; Wilders-Truschnig, M
Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
J Heart Lung Transplant. 1994; 13(3):405-411
Web of Science
PubMed
Google Scholar
** Iberer, F; Tscheliessnigg, KH; Freigassner, M; Auer, T; Kleinert, R; Wasler, A; Petutschnigg, B; Müller, H
Clinical experience with a monoclonal interleukin-2 receptor antibody (BT 563) for rejection therapy after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3237-3239
Web of Science
PubMed
** Iberer, F; Vujicic, R; Rödl, S; Wasler, A; Sabin, K; Koshsorur, A; Allmayer, T; Auer, T; Petutschnigg, B; Tscheliessnigg, KH
Effects of prostaglandin E1 therapy on cyclosporine A and creatinine levels after orthotopic heart transplantation.
Transplant Proc. 1994; 26(6):3246-3248
Web of Science
PubMed
** Iberer, F; Wasler, A; Tscheliessnigg, K; Petutschnigg, B; Auer, T; Müller, H; Rödl, S
Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(2):173-178
Web of Science
PubMed
** Eber, B; Brussee, H; Auer, T; Rotman, B
The St. Jude Valve: thrombolysis as the first line of therapy for cardiac valve thrombosis.
Circulation. 1993; 88(2):809-810
Doi: 10.1161/01.cir.88.2.809
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Iberer, F; Königsrainer, A; Wasler, A; Petutschnigg, B; Auer, T; Tscheliessnigg, K
Cardiac allograft harvesting after carbon monoxide poisoning. Report of a successful orthotopic heart transplantation.
J Heart Lung Transplant. 1993; 12(3):499-500
(- Case Report)
Web of Science
PubMed
** Kaltenböck, F; Gombotz, H; Tscheliessnigg, KH; Matzer, C; Winkler, G; Auer, T
[Right ventricular assist device (RVAD) in septic, fulminating pulmonary artery embolism].
Anaesthesist. 1993; 42(11):807-810
(- Case Report)
Web of Science
PubMed
** Wasler, A; Iberer, F; Tscheliessnigg, KH; Auer, T; Petutschnigg, B
Prostaglandin E1 in the pretransplantation period in patients with pulmonary hypertension.
J Heart Lung Transplant. 1993; 12(5):884-884
Web of Science
PubMed
** Iberer, F; Wasler, A; Tscheliessnigg, K; Vujicic, R; Rehak, P; Giegerl, E; Popper, HH; Kleinert, R; Berger, J; Auer, T
Prostaglandin E1 reduces the frequency of rejection after heart transplantation.
J Heart Lung Transplant. 1992; 11(4 Pt 1):727-732
Web of Science
PubMed
Google Scholar
** Wasler, A; Iberer, F; Tscheliessnigg, KH; Metzler, H; Gombotz, H; Berger, J; Auer, T; Petutschnigg, B
Preoperative prostaglandin E1 treatment to prevent right ventricular failure after orthotopic heart transplantation.
Transpl Int. 1992; 5 Suppl 1(4 Pt 1):S224-S227
Doi: 10.1007/978-3-642-77423-2_72
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Wasler, A; Petutschnigg, B; Iberer, F; Auer, T; Tscheliessnigg, KH
[Noninvasive monitoring of rejection in heart transplant patients. An overview of current status and use at a small transplant center].
Wien Klin Wochenschr. 1991; 103(4):105-110
Web of Science
PubMed
** Zenker, G; Tscheliessnig, KH; Metzler, H; Dakar, D; Mächler, H; Auer, T; Kandlhofer, B; Weihs, W; Rödl, S; Forche, G
[Postoperative behavior of pulmonary artery pressure and right ventricular remodeling following orthotopic heart transplantation].
Wien Med Wochenschr Suppl. 1989; 104(4):suppl 53-suppl 55
PubMed
** Auer, LM; Auer, T
Early surgical repair of large intracranial saccular aneurysms.
Acta Neurochir (Wien). 1988; 95(3-4):95-98
Doi: 10.1007/bf01790767
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Auer, LM; Auer, T; Sayama, I
Indications for surgical treatment of cerebellar haemorrhage and infarction.
Acta Neurochir (Wien). 1986; 79(2-4):74-79
Doi: 10.1007/bf01407448
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Auer, LM; Schneider, GH; Auer, T
Computerized tomography and prognosis in early aneurysm surgery.
J Neurosurg. 1986; 65(2):217-221
Doi: 10.3171/jns.1986.65.2.0217
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar